Kaempferol-loaded mucoadhesive nanoemulsion for intranasal administration reduces glioma growth in vitro

International Journal of Pharmaceutics

Volumn 543, Issue 1-2, 2018, Pages 214-223

  Colombo, Mariana ^a   Figueiró, Fabrício ^a   de Fraga Dias, Amanda ^a   Teixeira, Helder Ferreira ^a   Battastini, Ana Maria Oliveira ^a   Koester, Letícia Scherer ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Brain delivery; Glioma; Intranasal; Kaempferol; Mucoadhesive nanoemulsion

Indexed keywords

CHITOSAN; KAEMPFEROL; ANTINEOPLASTIC AGENT; KAEMPFEROL DERIVATIVE; NANOPARTICLE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CANCER INHIBITION; CELL DEATH; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; EX VIVO STUDY; GLIOMA; GLIOMA CELL; GLIOMA CELL LINE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; MUCOADHESION; NANOEMULSION; NONHUMAN; PRIORITY JOURNAL; RAT; SYNTHESIS; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL; ADHESION; ANATOMY AND HISTOLOGY; ANIMAL; BRAIN; BRAIN TUMOR; CELL SURVIVAL; DRUG EFFECT; EMULSION; INTRANASAL DRUG ADMINISTRATION; METABOLISM; NOSE MUCOSA; PIG; TUMOR CELL LINE; WISTAR RAT;

ADHESIVENESS; ADMINISTRATION, INTRANASAL; ANIMALS; ANTINEOPLASTIC AGENTS; BRAIN; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL SURVIVAL; EMULSIONS; GLIOMA; KAEMPFEROLS; NANOPARTICLES; NASAL MUCOSA; RATS, WISTAR; SWINE;

EID: 85044720636     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2018.03.055     Document Type: Article

References (57)

1. Alam, M.I., Beg, S., Samad, A., Baboota, S., Kohli, K., Ali, J., Ahuja, A., Akbar, M., Strategy for effective brain drug delivery. Eur. Feder. Pharm. Sci. 40 (2010), 385–403.
2. Amidi, M., Mastrobattista, E., Jiskoot, W., Hennink, W.E., Chitosan-based delivery systems for protein therapeutics and antigens. Adv. Drug Deliv. Rev. 62 (2010), 59–82.
3. Anitha, A., Maya, S., Deepa, N., Chennazhi, K.P., Nair, S.V., Jayakumar, R., Curcumin-loaded N, O-carboxymethyl chitosan nanoparticles for cancer drug delivery. J. Biomat. Sci. Polym. Edn. 23 (2012), 1381–1400.
4. Arora, P., Sharma, S., Garg, S., Permeability issues in nasal drug delivery. Drug Discov. Today 7 (2002), 967–975.
5. Bandaruk, Y., Mukai, R., Terao, J., Cellular uptake of quercetin and luteolin and their effects on monoamine oxidase-A in human neuroblastoma SH-SY5Y cells. Toxicol. Rep. 1 (2014), 639–649.
6. Barve, A., Chen, C., Hebbar, V., Desiderio, J., Saw, C.L., Kong, A.N., Metabolism, oral bioavailability and pharmacokinetics of chemopreventive kaempferol in rats. Biopharm. Drug Dispos. 30 (2009), 356–365.
7. Behin, A., Hoang-Xuan, K., Carpentier, A.F., Delattre, J.Y., Primary brain tumours in adults. Lancet 361 (2003), 323–331.
8. Bernkop-Schnurch, A., Dunnhaupt, S., Chitosan-based drug delivery systems. Eur. J. Pharm. Biopharm. 81 (2012), 463–469.
9. Bshara, H., Osman, R., Mansour, S., El-Shamy Ael, H., Chitosan and cyclodextrin in intranasal microemulsion for improved brain buspirone hydrochloride pharmacokinetics in rats. Carbohydr. Polym. 99 (2014), 297–305.
10. Caddeo, C., Manconi, M., Fadda, A.M., Lai, F., Lampis, S., Diez-Sales, O., Sinico, C., Nanocarriers for antioxidant resveratrol: formulation approach, vesicle self-assembly and stability evaluation. Colloids Surf. B Biointerfaces 111 (2013), 327–332.
11. Calderon-Montano, J.M., Burgos-Moron, E., Perez-Guerrero, C., Lopez-Lazaro, M., A review on the dietary flavonoid kaempferol. Mini-Rev. Med. Chem. 11 (2011), 298–344.
12. Callens, C., Ceulemans, J., Ludwig, A., Foreman, P., Remon, J.P., Rheological study on mucoadhesivity of some nasal powder formulations. Eur. J. Pharm. Biopharm. 55 (2003), 323–328.
13. Carvalho, F.C., Campos, M.L., Peccinini, R.G., Gremiao, M.P., Nasal administration of liquid crystal precursor mucoadhesive vehicle as an alternative antiretroviral therapy. Eur. J. Pharm. Biopharm. 84 (2013), 219–227.
14. Casettari, L., Illum, L., Chitosan in nasal delivery systems for therapeutic drugs. J. Control. Release 190 (2014), 189–200.
15. Chao, Y., Huang, C.T., Fu, L.T., Huang, Y.B., Tsai, Y.H., Wu, P.C., The effect of submicron emulsion systems on transdermal delivery of kaempferol. Chem. Pharm. Bull. 60 (2012), 1171–1175.
16. Chen, A.Y., Chen, Y.C., A review of the dietary flavonoid, kaempferol on human health and cancer chemoprevention. Food Chem. 138 (2013), 2099–2107.
17. Chen, Z.P., Sun, J., Chen, H.X., Xiao, Y.Y., Liu, D., Chen, J., Cai, H., Cai, B.C., Comparative pharmacokinetics and bioavailability studies of quercetin, kaempferol and isorhamnetin after oral administration of Ginkgo biloba extracts, Ginkgo biloba extract phospholipid complexes and Ginkgo biloba extract solid dispersions in rats. Fitoterapia 81 (2010), 1045–1052.
18. Cho, H.J., Ku, W.S., Termsarasab, U., Yoon, I., Chung, C.W., Moon, H.T., Kim, D.D., Development of udenafil-loaded microemulsions for intranasal delivery: in vitro and in vivo evaluations. Int. J. Pharm. 423 (2012), 153–160.
19. Cho, H.J., Park, J.H., Kaempferol Induces Cell Cycle Arrest in HT-29 Human Colon Cancer Cells. J. Cancer Prev. 18 (2013), 257–263.
20. Choi, E.J., Ahn, W.S., Kaempferol induced the apoptosis via cell cycle arrest in human breast cancer MDA-MB-453 cells. Nutr. Res. Pract. 2 (2008), 322–325.
21. Chuah, L.H., Roberts, C.J., Billa, N., Abdullah, S., Rosli, R., Cellular uptake and anticancer effects of mucoadhesive curcumin-containing chitosan nanoparticles. Colloids Surf. B 116 (2014), 228–236.
22. Colombo, M., Melchiades, G.d.L., Figueiró F., Battastini, A.M.O., Teixeira, H.F., Koester, L.S., Validation of an HPLC-UV method for analysis of Kaempferol-loaded nanoemulsion and its application to in vitro and in vivo tests. J. Pharm. Biomed. Anal. 145 (2017), 831–837.
23. Comfort, C., Garrastazu, G., Pozzoli, M., Sonvico, F., Opportunities and challenges for the nasal administration of nanoemulsions. Curr. Top. Med. Chem. 15 (2015), 356–368.
24. Dang, Q., Song, W., Xu, D., Ma, Y., Li, F., Zeng, J., Zhu, G., Wang, X., Chang, L.S., He, D., Li, L., Kaempferol suppresses bladder cancer tumor growth by inhibiting cell proliferation and inducing apoptosis. Mol. Carcinog. 54 (2015), 831–840.
25. Devi, K.P., Malar, D.S., Nabavi, S.F., Sureda, A., Xiao, J., Nabavi, S.M., Daglia, M., Kaempferol and inflammation: From chemistry to medicine. Pharmacol. Res. 99 (2015), 1–10.
26. Frohlich, E., The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles. Int. J. Nanomed. 7 (2012), 5577–5591.
27. Furubayashi, T., Inoue, D., Kamaguchi, A., Higashi, Y., Sakane, T., Influence of formulation viscosity on drug absorption following nasal application in rats. Drug Metab. Pharmacokinet. 22 (2007), 206–211.
28. Hillaireau, H., Couvreur, P., Nanocarriers’ entry into the cell: relevance to drug delivery. Cell. Mol. Life Sci. 66 (2009), 2873–2896.
29. Illum, L., Transport of drugs from the nasal cavity to the central nervous system. Eur. J. Pharm. Sci. 11 (2000), 1–18.
30. Jeong, J.C., Kim, M.S., Kim, T.H., Kim, Y.K., Kaempferol induces cell death through ERK and Akt-dependent down-regulation of XIAP and survivin in human glioma cells. Neurochem. Res. 34 (2009), 991–1001.
31. Kumar, M., Misra, A., Babbar, A.K., Mishra, A.K., Mishra, P., Pathak, K., Intranasal nanoemulsion based brain targeting drug delivery system of risperidone. Int. J. Pharm. 358 (2008), 285–291.
32. Kumar, M., Pathak, K., Misra, A., Formulation and characterization of nanoemulsion-based drug delivery system of risperidone. Drug Dev. Ind. Pharm. 35 (2009), 387–395.
33. Liu, J., Xu, L., Liu, C., Zhang, D., Wang, S., Deng, Z., Lou, W., Xu, H., Bai, Q., Ma, J., Preparation and characterization of cationic curcumin nanoparticles for improvement of cellular uptake. Carbohydr. Polym. 90 (2012), 16–22.
34. Liu, R., Wang, X., Zhao, Y., Wang, Z., Du, L., The uptake behaviors of kaempferol and quercetin through rat primary cultured cortical neurons. Biomed. Chromatogr. 20 (2006), 1178–1184.
35. Lopez-Sanchez, C., Martin-Romero, F.J., Sun, F., Luis, L., Samhan-Arias, A.K., Garcia-Martinez, V., Gutierrez-Merino, C., Blood micromolar concentrations of kaempferol afford protection against ischemia/reperfusion-induced damage in rat brain. Brain Res. 28 (2007), 123–137.
36. Luo, H., Jiang, B., Li, B., Li, Z., Jiang, B.H., Chen, Y.C., Kaempferol nanoparticles achieve strong and selective inhibition of ovarian cancer cell viability. Int. J. Nanomed. 7 (2012), 3951–3959.
37. Mistry, A., Stolnik, S., Illum, L., Nanoparticles for direct nose-to-brain delivery of drugs. Int. J. Pharm. 379 (2009), 146–157.
38. Nakatsuma, A., Fukami, T., Suzuki, T., Furuishi, T., Tomono, K., Hidaka, S., Effects of kaempferol on the mechanisms of drug resistance in the human glioblastoma cell line T98G. Pharmazie 65 (2010), 379–383.
39. Pardeshi, C.V., Belgamwar, V.S., Direct nose to brain drug delivery via integrated nerve pathways bypassing the blood-brain barrier: an excellent platform for brain targeting. Expert Opin. Drug Deliv. 10 (2013), 957–972.
40. Rothwell, J.A., Day, A.J., Morgan, M.R., Experimental determination of octanol-water partition coefficients of quercetin and related flavonoids. J. Agric. Food Chem. 53 (2005), 4355–4360.
41. Ruweler, M., Anker, A., Gulden, M., Maser, E., Seibert, H., Inhibition of peroxide-induced radical generation by plant polyphenols in C6 astroglioma cells. Toxicol. In Vitro 22 (2008), 1377–1381.
42. Seibert, H., Maser, E., Schweda, K., Seibert, S., Gulden, M., Cytoprotective activity against peroxide-induced oxidative damage and cytotoxicity of flavonoids in C6 rat glioma cells. Food Chem. Toxicol. 49 (2011), 2398–2407.
43. Shah, B., Khunt, D., Misra, M., Padh, H., Non-invasive intranasal delivery of quetiapine fumarate loaded microemulsion for brain targeting: Formulation, physicochemical and pharmacokinetic consideration. Eur. J. Pharm. Sci. 91 (2016), 196–207.
44. Shah, B.M., Misra, M., Shishoo, C.J., Padh, H., Nose to brain microemulsion-based drug delivery system of rivastigmine: formulation and ex-vivo characterization. Drug Deliv. 22 (2015), 918–930.
45. Sharma, V., Joseph, C., Ghosh, S., Agarwal, A., Mishra, M.K., Sen, E., Kaempferol induces apoptosis in glioblastoma cells through oxidative stress. Mol. Cancer Ther. 6 (2007), 2544–2553.
46. Siegelin, M.D., Reuss, D.E., Habel, A., Herold-Mende, C., von Deimling, A., The flavonoid kaempferol sensitizes human glioma cells to TRAIL-mediated apoptosis by proteasomal degradation of survivin. Mol. Cancer Ther. 7 (2008), 3566–3574.
47. Silva, A.O., Dalsin, E., Onzi, G.R., Filippi-Chiela, E.C., Lenz, G., The regrowth kinetic of the surviving population is independent of acute and chronic responses to temozolomide in glioblastoma cell lines. Exp. Cell Res. 348 (2016), 177–183.
48. Song, W., Dang, Q., Xu, D., Chen, Y., Zhu, G., Wu, K., Zeng, J., Long, Q., Wang, X., He, D., Li, L., Kaempferol induces cell cycle arrest and apoptosis in renal cell carcinoma through EGFR/p38 signaling. Oncol. Rep. 31 (2014), 1350–1356.
49. Sood, S., Jain, K., Gowthamarajan, K., Optimization of curcumin nanoemulsion for intranasal delivery using design of experiment and its toxicity assessment. Colloids Surf. B Biointerfaces 113 (2014), 330–337.
50. Stupp, R., Hegi, M.E., Mason, W.P., van den Bent, M.J., Taphoorn, M.J., Janzer, R.C., Ludwin, S.K., Allgeier, A., Fisher, B., Belanger, K., Hau, P., Brandes, A.A., Gijtenbeek, J., Marosi, C., Vecht, C.J., Mokhtari, K., Wesseling, P., Villa, S., Eisenhauer, E., Gorlia, T., Weller, M., Lacombe, D., Cairncross, J.G., Mirimanoff, R.O., Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 10 (2009), 459–466.
51. Sultana, B., Anwar, F., Flavonols (kaempeferol, quercetin, myricetin) contents of selected fruits, vegetables and medicinal plants. Food Chem. 108 (2008), 879–884.
52. USP, The United States Pharmacopeia. 33 ed, 2011, United States Pharmacopeia Convetional, Rockville.
53. Van Meir, E.G., Hadjipanayis, C.G., Norden, A.D., Shu, H.K., Wen, P.Y., Olson, J.J., Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma. CA Cancer J. Clin. 60 (2010), 166–193.
54. van Woensel, M., Wauthoz, N., Rosiere, R., Amighi, K., Mathieu, V., Lefranc, F., van Gool, S.W., de Vleeschouwer, S., Formulations for Intranasal Delivery of Pharmacological Agents to Combat Brain Disease: A New Opportunity to Tackle GBM?. Cancers 5 (2013), 1020–1048.
55. Vllasaliu, D., Exposito-Harris, R., Heras, A., Casettari, L., Garnett, M., Illum, L., Stolnik, S., Tight junction modulation by chitosan nanoparticles: comparison with chitosan solution. Int. J. Pharm. 400 (2010), 183–193.
56. Yang, L., Gao, S., Asghar, S., Liu, G., Song, J., Wang, X., Ping, Q., Zhang, C., Xiao, Y., Hyaluronic acid/chitosan nanoparticles for delivery of curcuminoid and its in vitro evaluation in glioma cells. Int. J. Biol. Macromol. 72 (2015), 1391–1401.
57. Zhu, L., Ma, J., Jia, N., Zhao, Y., Shen, H., Chitosan-coated magnetic nanoparticles as carriers of 5-fluorouracil: preparation, characterization and cytotoxicity studies. Colloids Surf. B 68 (2009), 1–6.